| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
6,601 |
4,251 |
$1.70M |
| J0178 |
Injection, aflibercept, 1 mg |
396 |
250 |
$871K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
484 |
325 |
$358K |
| 92134 |
|
6,315 |
5,837 |
$205K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,488 |
2,295 |
$115K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
110 |
65 |
$104K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,454 |
813 |
$96K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
452 |
445 |
$22K |
| 92226 |
|
1,053 |
631 |
$21K |
| 92250 |
|
320 |
291 |
$14K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
179 |
168 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
172 |
155 |
$6K |
| 92235 |
|
39 |
37 |
$3K |
| 92202 |
|
58 |
57 |
$960.03 |